Parp Inhibitors in BRCA Mutated Breast Cancer

Professor Giuseppe Curigliano, Co-Chair of the Division of Medical Oncology at European Institute of Oncology (EIO), Clinician and Researcher specializing in Breast Cancer, speaks from ESMO 2017. Author: patientpower Added: 10/19/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts